​​

News

Get the latest news from Rigshospitalet.
192 news stories
1-50 | 51-100 | 101-150 | 151-192 | >

Patients with blood poisoning do not have to take so much fluid

Halving fluids to treat intensive-care patients with blood poisoning causes neither higher mortality nor more serious side effects according to a new trial. ​

Cornerstone laid for Mary Elizabeth’s Hospital

Her Royal Highness Crown Princess Mary has laid the cornerstone for Rigshospitalet's new hospital for children, teens, expecting mothers and their families. Mary Elizabeth’s Hospital - Rigshospitalet for Children, Teens and Expecting Families will be a pioneering hospital in which life abounds on the patients’ terms.

New brain-haemorrhage treatment tested on patients for the first time

Researchers from Rigshospitalet have launched first-in-human trials of a groundbreaking new treatment principle for brain haemorrhages. The professor behind the trials has been working on this breakthrough for 25 years, and he is now about to embark on the second treatment breakthrough in his career. ​​​

Good results with surgery for malignant pleural mesothelioma

All the malignant pleural mesothelioma operations in Denmark are performed by just a small group of experts. This has led to large improvements in the survival rate for a disease that was untreatable 20 years ago.​

Alzheimer’s Disease: The Identification of 75 Genetic Risk Factors Brings New Insights

Researchers in Europe, the US and Australia have identified 75 regions of the genome that are associated with Alzheimer's disease. Forty-two of these regions are novel, meaning that they have never before been implicated in the disease.​​

Paracetamol can impair men’s ability to make women pregnant

New research has disconcerting news: Large quantities of paracetamol seem to affect the function of sperm cells and possibly men’s ability to make women pregnant.​

Best in the world to detect cancer mutations

The Center for Genomic Medicine has been awarded the gold medal in genetic variant detection from genomic data in cancer diagnostics. The challenge was organised by the American Food and Drug Administration (FDA) and counted participants from throughout the world.

Gene researchers can now explain different types of migraine

The world's largest gene study on migraine describes, for the first time, the genetic differences between migraine with and without aura. The results look promising for developing new medicines, says the Danish co-author.​

BørneRiget to have royal new name

​Rigshospitalet's new hospital for children, young people, expecting mothers and their families will be named after Her Royal Highness Crown Princess Mary. The hospital is to open in four years, and it will be called ‘Mary Elizabeth’s Hospital - Rigshospitalet for Children, Teens and Expecting Families´.

Not all patients with COVID-19 need the same medicine

​Some patients with COVID pneumonia benefit from antibody medicine to combat the virus. For others, this is no help at all - and perhaps it has the opposite effect.

​ Chemicals and fossil fuels could be behind falling birth rates

​Alarming new international study published in the prestigious journal Nature Reviews Endocrinology.

Well-known drug could help the most severely affected Covid-19 patients in intensive-care departments

​Damage to the body's most important organs is reduced significantly in mechanically ventilated patients with corona if they receive a medicine called prostacyclin. This is the result of a new study from Rigshospitalet.

French intensive care physician receives this year's international KFJ Award

Professor Elie Azoulay has received Rigshospitalet's international KFJ Award for his ground-breaking research on some of the most seriously ill intensive care patients with blood cancer.

Expert group: pregnant women should be wary of taking paracetamol

​Pain-relieving medication with paracetamol should not be taken during pregnancy unless there are good medical reasons for doing so, and only at the lowest possible dosage.

Scottish professor wins prestigious Danish research award

The International KFJ research award from Copenhagen University Hospital – Rigshospitalet goes to professor John McMurray from the University of Glasgow. The Scottish research heavyweight has been working with Danish heart failure researchers for more than a decade.

Scottish specialist in the heart failure wins prestigious Danish award

Rigshospitalet's international KFJ Award goes to Professor John McMurray from the University of Glasgow. The Scottish research heavyweight has been working with Danish heart researchers for more than ten years.

Men with testicular cancer stand a good chance of having children

​A new study from Rigshospitalet shows that men with testicular cancer have a far better chance of obtaining fatherhood after treatment than previously assumed. In fact, statistically around half of all men who have undergone treatment for testicular cancer have the same chance of obtaining fatherhood as the rest of the male population.

A tiny gene mutation with a huge significance for male sperm production

New research from Rigshospitalet explains why some men produce no sperm cells at all, meaning that fertility treatment can never help them.

Researchers link drug with higher risk of tumours in the brain membrane

​A new study from Rigshospitalet has demonstrated a link between the drug cyproterone acetate (Androcur®) and a type of brain tumour known as a meningioma. Among other things, the drug is used for male-to-female transgender hormone therapy.

Danish-Norwegian registry study on adverse reactions after AstraZeneca vaccination has now been published

​In a Danish-Norwegian collaboration, researchers have shown a slightly increased rate of rare but serious types of cerebral blood clots as well as a generally increased rate of venous blood clots following vaccination with the AstraZeneca vaccine. The risk of such adverse events is considered very low for the individual vaccine recipient.

Research breakthrough provides hope for a new treatment for men with low sperm quality

Researchers at Rigshospitalet and Harvard University are the first in the world to prove that a drug against osteoporosis also increases the number of sperm cells in men with low sperm quality. There is hope the drug can be used in a new, promising treatment for men with low sperm quality.

New research: Considerably lower incidence of cervical cancer for young women vaccinated against HPV

​A major Danish study has showed that the incidence of cervical cancer is up to 86% lower for women who received HPV vaccine before the age of 20. The researchers behind the study believe that it may be possible to almost eradicate cervical cancer in Denmark.

Rigshospitalet launches pitching tool for healthcare solutions

Rigshospitalet is now making it easier for companies and start-ups to pitch innovative health- and care solutions with a new on-line “Pitch –and-match” tool. The aim of the tool is to match innovative ideas and technologies from start-ups to clinics with specific needs.

Migraine pioneers receive world’s most prestigious brain research prize

​Professors Jes Olesen and Lars Edvinsson from Rigshospitalet and the University of Copenhagen receive the most prestigious brain research prize in the world, the Lundbeck Foundation Brain Prize, which they will be the first researchers in the Nordic countries to receive. The prize celebrates 40 years of research into migraine, which is now recognised as a treatable neurological disease.

Computer can determine whether you’ll die from COVID

​Using patient data, artificial intelligence can make a 90 percent accurate assessment of whether a person will die from COVID-19 or not. Now Danish hospitals will use the data to predict how many patients will need a respirator 5 days later.

Global COVID-19 study comes with rapid results on first antibody

The first treatment results from a worldwide COVID-19 study show that treatment with the antibody LY-CoV555 has no effect on patients in hospital. Three new antibodies now to be tested.

Denmark trial measures effectiveness of adding a mask recommendation to other public health measures for preventing SARS-CoV-2 infection

​​A randomized trial of more than 6,000 participants in Denmark adds new evidence to what is known about whether masks protect the wearer from SARS-CoV-2 infection.

Rigshospitalet tests a black box in an operating room

​Can a black box in operating rooms increase patient safety and reduce disruptions? This is now being tested in a new research and development project at Rigshospitalet.

Healthy Lifestyle Cuts the Risk of Dementia in Half

​New research shows that a healthy cardiovascular lifestyle almost cuts the risk of age-related dementia in half. The results open up the possibility that cardiovascular disease and dementia can be prevented simultaneously.

A unique Danish Covid-19 study presents its data

​What happened to Covid-19 patients in Danish intensive-care departments during the first wave of Corona in the spring

Large increase in HPV-related head and neck cancer in Denmark

New research from Rigshospitalet shows that there has been a threefold increase in HPV-related oropharyngeal cancer cases over the past 18 years.

Specially designed virtual reality game for children who are afraid of needles

The Paediatric Pain Knowledge Centre at Rigshospitalet and the virtual reality (VR) company Khora have developed a specially designed VR game that can help children sit still, for example while blood samples are being taking, and distract them from the needle and the pain.

Pregnancy loss in Denmark over the past 40 years

​A new study of pregnancies in Denmark over the past 40 years shows that almost one in ten of all pregnancies end in a miscarriage, and the risk increases with age.

GLP-1-Based Treatment of Diabetes Does not Cause Pancreatitis

The commonly used treatment for type 2 diabetes and obesity, GLP-1, does not cause pancreatitis. The treatment is known to increase two markers of pancreatitis, but now, a new study shows a harmless, physiological explanation.

Physicians at Rigshospitalet perform the first ever artificial heart operation in Denmark

Physicians at Rigshospitalet are the first in Northern Europe to have implanted the Carmat fully artificial heart into a patient. Carmat can be an alternative to a heart transplant or a temporary solution for patients waiting for a transplant.

Danish Researchers Find New Breast Cancer Gene in Young People

New research shows for the first time that RBBP8 gene variants may lead to the development of breast cancer in very young women.

Rigshopitalet to head trials of drug to treat COVID-19

​European efforts to test whether the Remdesivir drug works against COVID-19 are to be managed from Rigshospitalet.

“Early puberty” is perhaps not early

​New research from Rigshospitalet gives rise to reconsidering conceptions of what is normal for puberty and “early puberty”

Global Study Maps Cancer Mutations in Large Catalogue

​Mutations in 38 different types of cancer have been mapped by means of whole genome analysis by an international team of researchers. The researchers have compiled a catalogue of the cancer mutations that will be available worldwide to doctors and researchers.

Fish oil supplements associated with male reproductive health

​Taking fish oil supplements may improve sperm quality in healthy young men, a new study Danish study suggests.

Rigshospitalet opens new North Wing

​In the presence of HM The Queen, the new treatment building with almost 200 private rooms and 33 modern operating theatres opened on 14 January 2020.

10 years after sepsis break-through: We’re building a test machine

​Milestone clinical trial at Rigshospitalet has gone around the world. New figures show that the trial has saved DKK 52 million, 4,400 unnecessary blood transfusions and 1,184 lives - and that’s in Denmark alone.

Genetic research pioneer wins prestigious award

​Icelandic professor, Kari Stefansson, has conducted groundbreaking research within population genetics with his company deCODE genetics, and he is this year's winner of Rigshospitalet's International KFJ Award.

Icelandic pioneer in genetic research wins prestigious award

Icelandic professor, Kari Stefansson, has conducted groundbreaking research within population genetics with his company deCODE genetics, and he is this year's winner of Rigshospitalet's International KFJ Award.

Large grant for research into dangerous bacteria

​The Novo Nordisk Foundation has granted DKK 60 mill. (EUR 7.9 mill.) to a new research centre in persistent bacterial infections. Such are hard to treat with antibiotics and are one of the most serious global health problems.

Millions for research into physical training prior to cancer surgery

​With grants totalling more than DKK 10 mill. (EUR 1.3 mill.), TrygFonden’s Centre for Physical Activity Research at Rigshospitalet can now examine whether targeted physical training can help cancer patients through major surgery.

Pregnancy Loss Not Linked to Later Cancer

​COPENHAGEN - A new study finds that pregnancy loss, even if repeated, is not associated with later cancer development. The study is the largest of its kind, investigating multiple types of cancer, and both common and rare types of pregnancy loss.

Research project will improve the quality of life of people with chronic arthritis

​Senior Researcher and nurse Bente Appel Esbensen Center for Rheuma-tology and Spine Diseases, Rigshospitalet, receives DKK 7.5 million from The Novo Nordisk Foundation for a major new research project that will provide new tools to nurses and other healthcare profes-sionals to help them further improve the quality of life of people with chronic arthritis.

Rigshospitalet-spinout to develop cancer-drug in Copenhagen-based 'Creation House'

​The biotech company ADCendo ApS, a spinout-company from the Biotech Research and Innovation Centre within University of Copenhagen and Rigshospitalet, has been accepted into the start up-programme Creation House at the BioInnovation Institute. Along with the enrolment comes guidance, support, advanced laboratories and a convertible loan of 10 million DKK.

Saves thousands of lives as a matter of routine

​Since its introduction 30 years ago, percutaneous coronary intervention (PCI) has changed from being a nerve-racking journey into unknown territory to an everyday procedure. However, there is a reverse side to this successful, now routine procedure.
192 news stories
1-50 | 51-100 | 101-150 | 151-192 | >
Responsible editor
Webgruppen på Rigshospitalet